BSSXG is effective to treat MDS-RA, and worthy of further study and development.
补髓生血颗粒是防治mds的有效药物，值得进一步研究、开发和利用。
BSSXG combined with ATRA is effective to treat MDS-RA, and worthy of further study and development.
补髓生血颗粒为主配合小剂量atra是治疗MDS - RA的有效方法，值得在临床上推广和进一步深入研究。
Methods The clinical characteristics and experimental data of 24 patients with MDS-RA and 59 cases with CAA were analysed.
比较24例骨髓异常增生综合征难治性贫血与59例慢性再生障碍性贫血的临床特点和实验室资料。
Methods The clinical characteristics and experimental data of 24 patients with MDS-RA and 59 cases with CAA were analysed.
比较24例骨髓异常增生综合征难治性贫血与59例慢性再生障碍性贫血的临床特点和实验室资料。
应用推荐